These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38224852)

  • 1. Dual effect of cardiac FKBP12.6 overexpression on excitation-contraction coupling and the incidence of ventricular arrhythmia depending on its expression level.
    Gandon-Renard M; Val-Blasco A; Oughlis C; Gerbaud P; Lefebvre F; Gomez S; Journé C; Courilleau D; Mercier-Nomé F; Pereira L; Benitah JP; Gómez AM; Mercadier JJ
    J Mol Cell Cardiol; 2024 Mar; 188():15-29. PubMed ID: 38224852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
    Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
    Liu N; Colombi B; Memmi M; Zissimopoulos S; Rizzi N; Negri S; Imbriani M; Napolitano C; Lai FA; Priori SG
    Circ Res; 2006 Aug; 99(3):292-8. PubMed ID: 16825580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
    Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
    Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.
    Zhang X; Tallini YN; Chen Z; Gan L; Wei B; Doran R; Miao L; Xin HB; Kotlikoff MI; Ji G
    Cardiovasc Res; 2009 Nov; 84(2):253-62. PubMed ID: 19578067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.
    Guo T; Cornea RL; Huke S; Camors E; Yang Y; Picht E; Fruen BR; Bers DM
    Circ Res; 2010 Jun; 106(11):1743-52. PubMed ID: 20431056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH; Higgs GV; Lai FA
    Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.
    Xiao J; Tian X; Jones PP; Bolstad J; Kong H; Wang R; Zhang L; Duff HJ; Gillis AM; Fleischer S; Kotlikoff M; Copello JA; Chen SR
    J Biol Chem; 2007 Nov; 282(48):34828-38. PubMed ID: 17921453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.
    Wehrens XH; Lehnart SE; Huang F; Vest JA; Reiken SR; Mohler PJ; Sun J; Guatimosim S; Song LS; Rosemblit N; D'Armiento JM; Napolitano C; Memmi M; Priori SG; Lederer WJ; Marks AR
    Cell; 2003 Jun; 113(7):829-40. PubMed ID: 12837242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Loaiza R; Benkusky NA; Powers PP; Hacker T; Noujaim S; Ackerman MJ; Jalife J; Valdivia HH
    Circ Res; 2013 Jan; 112(2):298-308. PubMed ID: 23152493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.
    Kryshtal DO; Blackwell DJ; Egly CL; Smith AN; Batiste SM; Johnston JN; Laver DR; Knollmann BC
    Circ Res; 2021 Feb; 128(3):321-331. PubMed ID: 33297863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
    Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.
    Yang Y; Guo T; Oda T; Chakraborty A; Chen L; Uchinoumi H; Knowlton AA; Fruen BR; Cornea RL; Meissner G; Bers DM
    Circ Res; 2014 Jan; 114(2):295-306. PubMed ID: 24186966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.